Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 445 for CELL
Company Exchange Symbol Last price Quote change Market cap
Advanced Cell Technology, Inc. OTCMKTS ACTC 0.0802 -0.0058 (-6.74%) 224.49M
Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the ...
Brightpoint, Inc. NASDAQ CELL 0.0000
Brightpoint, Inc.(BrightPoint) is engaged in providing device lifecycle services to the wireless industry. The Company provides customized logistic services ...
StemCells Inc NASDAQ STEM 1.73 0.00 (-0.29%) 117.84M
(StemCells) is engaged in the research, development, and commercialization of stem cell therapeutics and related tools and technologies for academia and ...
Brainstorm Cell Therapeutics Inc OTCBB BCLI 0.350 -0.003 (-0.85%) 63.92M
Brainstorm Cell Therapeutics Inc. (Brainstorm) is a biotechnology company developing adult stem cell therapies for debilitating neurodegenerative disorders, ...
International Stem Cell Corp OTCMKTS ISCO 0.119 -0.010 (-8.08%) 25.52M
International Stem Cell Corporation is a developmental-stage biotechnology company. ... The Company's wholly owned subsidiary Lifeline Cell Technology, ...
Stem Cell Innovations Inc. OTCMKTS SCLL
Stem Cell Innovations, Inc. has a business relating to the use of the Company's C3A human liver cell line in the field of drug discovery and toxicology ...
Millennium Cell Inc. OTCMKTS MCELQ 0.0005 +0.0004 (400.00%) 37,812.00
Millennium Cell Inc. (Millennium Cell) is engaged in the development of hydrogen fuel cartridge technology and designs, as well as hydrogen batteries ...
BioTime, Inc. NYSEMKT BTX 2.75 -0.03 (-1.08%) 198.41M
Its commercial strategy is focused on its line of research products, such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, ...
Harvard Bioscience, Inc. NASDAQ HBIO 4.89 -0.01 (-0.20%) 156.27M
Harvard Bioscience, Inc. is a global developer, manufacturer and marketer of a range of specialized products, apparatus and scientific instruments, ...
Ceramic Fuel Cells Limited LON CFU 0.650 -0.025 (-3.70%) 10.14M
Ceramic Fuel Cells Limited is engaged in commercializing Solid Oxide Fuel Cell ( SOFC) technology to generate electricity from natural gas and renewable ...
CRYO-CELL International, Inc. OTCMKTS CCEL 2.51 +0.11 (4.58%) 25.38M
Cryo-Cell International, Inc. (Cryo-Cell) is engaged in cellular processing and cryogenic storage, with a focus on the collection and preservation of ...
THERAPY CELLS INC OTCMKTS TCEL 0.0026 -0.0030 (-53.57%) 432,900.00
Celgene Corporation NASDAQ CELG 89.12 +2.46 (2.84%) 71.37B
... signaling pathways in cancer and immune cells, immunomodulation in cancer and autoimmune diseases, and therapeutic application of cell therapies.
Intergrative Stem Cell Holdings Inc OTCMKTS YFRM 0.0022 +0.0001 (4.76%) 22,000.00
Intergrative Stem Cell Holdings Inc., formerly YaFarm Technologies, Inc., is a Web development and Web hosting company. The Company, through its wholly ...
Zhongyuan Union Stem Cell Bio-Engng Corp SHA 600645 28.60 -1.45 (-4.83%) 9.99B
ZHONGYUAN UNION STEM CELL BIOENGINEERING CO. is principally engaged in the detection and storage of stem cell sources. Through its subsidiaries, the Company ...
Ceramic Fuel Cells Limited ASX CFU 0.0120 0.0000 (0.00%) 21.02M
Ceramic Fuel Cells Limited is engaged in commercializing Solid Oxide Fuel Cell ( SOFC) technology to generate electricity from natural gas and renewable ...
Pacific Fuel Cell Corp OTCMKTS PFCEQ 0.0000
Pacific Fuel Cell Corp. manufactures bipolar plates, end plates and flow ... Plates are essential elements of a fuel cell stack in that they provide the ...
ImmunoCellular Therapeutics Ltd NYSEMKT IMUC 1.00 +0.07 (7.53%) 57.92M
ICT-107, the pipeline product, is a Phase II therapeutic dendritic cell (DC) vaccine for the treatment of glioblastoma multiforme (GBM), the common and ...
Pathfinder Cell Therapy Inc OTCMKTS SYMD
Pathfinder Cell Therapy, Inc. is a development-stage medicine company that develops cell-based therapies for the treatment of a range of diseases and ...
Athersys, Inc. NASDAQ ATHX 1.66 +0.07 (4.40%) 127.90M
During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in ...